New Parkinson’s trial platform could “dramatically speed up the search for a cure”

News

Author: Saskia MairPublished: 14 May 2020

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

Scientists have proposed the use of a multi-arm, multi-stage trial platform (MAMS) to assess different potential treatments for Parkinson’s and help progress the search for a cure.

This would depart from conventional clinical procedures, allowing several potential treatments to be assessed simultaneously. In a continuous process, each treatment ‘arm’ is evaluated and unsuccessful ‘arms’ of the trial are dropped, enabling a far more cost and time efficient system.

Currently, MAMS are used to evaluate treatments for certain types of cancer – and work is underway to develop MAMS for other neurodegenerative conditions.

Camille Buchholz Carroll, associate professor at the University of Plymouth, UK, and study author, said that MAMS trials could “dramatically speed up the search for a cure”.

She said: “We have the opportunity to learn from the experience in these other conditions and design a new trial that will work for people with Parkinson’s.”

To read more on this topic click here.

For more information on the latest Parkinson’s research please visit the EPDA website.


Read more:

Can higher levels of caffeine and uric acid prevent Parkinson’s?

White blood cells could help diagnose people at risk of Parkinson’s, study finds

Go Back

Share this story

Comments


Related articles


Perspectives

Who said what: QoTW 18.06.15

Our favourite quotes of the week from around the web

READ MORE

Episodes

Podcast roundup: conversations on the reality of Parkinson’s

A roundup of the Parkinson’s Life podcast

READ MORE

Perspectives

Billy Connolly “doing really well, funny as ever,” says wife

Pamela Stephenson gives an update on her husband’s condition

READ MORE